Muñoz-Mayorga Daniel, Guerra-Araiza Christian, Torner Luz, Morales Teresa
Departamento de Neurobiología Celular y Molecular, Instituto de Neurobiología, Universidad Nacional Autónoma de México, Querétaro, Mexico.
Unidad de Investigación Médica en Farmacología, Hospital de Especialidades, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Mexico City, Mexico.
Front Endocrinol (Lausanne). 2018 Mar 28;9:133. doi: 10.3389/fendo.2018.00133. eCollection 2018.
Sex differences are important to consider when studying different psychiatric, neurodevelopmental, and neurodegenerative disorders, including Alzheimer's disease (AD). These disorders can be affected by dimorphic changes in the central nervous system and be influenced by sex-specific hormones and neuroactive steroids. In fact, AD is more prevalent in women than in men. One of the main characteristics of AD is the formation of neurofibrillary tangles, composed of the phosphoprotein Tau, and neuronal loss in specific brain regions. The scope of this work is to review the existing evidence on how a set of hormones (estrogen, progesterone, and prolactin) affect tau phosphorylation in the brain of females under both physiological and pathological conditions.
在研究包括阿尔茨海默病(AD)在内的不同精神、神经发育和神经退行性疾病时,性别差异是需要考虑的重要因素。这些疾病可能会受到中枢神经系统双态变化的影响,并受到性别特异性激素和神经活性甾体的影响。事实上,AD在女性中比在男性中更为普遍。AD的主要特征之一是由磷蛋白Tau组成的神经原纤维缠结的形成,以及特定脑区的神经元丧失。这项工作的范围是回顾现有证据,即一组激素(雌激素、孕酮和催乳素)在生理和病理条件下如何影响雌性大脑中的tau磷酸化。